 | • レポートコード：QFJ1-5847 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、禁煙用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ニコチン薬、ニコチン置換療法（NRT））、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・禁煙用医薬品の市場動向 ・企業の競争状況、市場シェア ・禁煙用医薬品の種類別市場規模と予測2016-2027（非ニコチン薬、ニコチン置換療法（NRT）） ・禁煙用医薬品の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・禁煙用医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・禁煙用医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・禁煙用医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・禁煙用医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・禁煙用医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Nicotek、Cipla、GlaxoSmithKline、Dr Reddy's Laboratories、Johnson & Johnson、Fontem Ventures、Pfizer、NovartisNjoy Inc、Perrigo and Reynolds American Inc.） ・結論 |
Smoking cessation drugs are de-addiction drugs for smoking. The alkaloid compound called nicotine causes addictive dependency on cigarettes and other smoking products. Smoking cessation results in withdrawal symptoms such as anxiety, strong cravings, depressing mood, insomnia and mood alterations.
Market Analysis and Insights: Global Medications for Smoking Cessation Market
The global Medications for Smoking Cessation market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Medications for Smoking Cessation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Medications for Smoking Cessation market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Medications for Smoking Cessation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Medications for Smoking Cessation market.
Global Medications for Smoking Cessation Scope and Market Size
Medications for Smoking Cessation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Medications for Smoking Cessation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Non Nicotine Drugs
Nicotine Replacement Therapy (NRT)
Segment by Application
Hospital Pharmacies
Retailer Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Nicotek
Cipla
GlaxoSmithKline
Dr Reddy’s Laboratories
Johnson & Johnson
Fontem Ventures
Pfizer
NovartisNjoy Inc
Perrigo and Reynolds American Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medications for Smoking Cessation Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Non Nicotine Drugs
1.2.3 Nicotine Replacement Therapy (NRT)
1.3 Market by Application
1.3.1 Global Medications for Smoking Cessation Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retailer Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Medications for Smoking Cessation Market Perspective (2016-2027)
2.2 Medications for Smoking Cessation Growth Trends by Regions
2.2.1 Medications for Smoking Cessation Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Medications for Smoking Cessation Historic Market Share by Regions (2016-2021)
2.2.3 Medications for Smoking Cessation Forecasted Market Size by Regions (2022-2027)
2.3 Medications for Smoking Cessation Industry Dynamic
2.3.1 Medications for Smoking Cessation Market Trends
2.3.2 Medications for Smoking Cessation Market Drivers
2.3.3 Medications for Smoking Cessation Market Challenges
2.3.4 Medications for Smoking Cessation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medications for Smoking Cessation Players by Revenue
3.1.1 Global Top Medications for Smoking Cessation Players by Revenue (2016-2021)
3.1.2 Global Medications for Smoking Cessation Revenue Market Share by Players (2016-2021)
3.2 Global Medications for Smoking Cessation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Medications for Smoking Cessation Revenue
3.4 Global Medications for Smoking Cessation Market Concentration Ratio
3.4.1 Global Medications for Smoking Cessation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medications for Smoking Cessation Revenue in 2020
3.5 Medications for Smoking Cessation Key Players Head office and Area Served
3.6 Key Players Medications for Smoking Cessation Product Solution and Service
3.7 Date of Enter into Medications for Smoking Cessation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medications for Smoking Cessation Breakdown Data by Type
4.1 Global Medications for Smoking Cessation Historic Market Size by Type (2016-2021)
4.2 Global Medications for Smoking Cessation Forecasted Market Size by Type (2022-2027)
5 Medications for Smoking Cessation Breakdown Data by Application
5.1 Global Medications for Smoking Cessation Historic Market Size by Application (2016-2021)
5.2 Global Medications for Smoking Cessation Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Medications for Smoking Cessation Market Size (2016-2027)
6.2 North America Medications for Smoking Cessation Market Size by Type
6.2.1 North America Medications for Smoking Cessation Market Size by Type (2016-2021)
6.2.2 North America Medications for Smoking Cessation Market Size by Type (2022-2027)
6.2.3 North America Medications for Smoking Cessation Market Size by Type (2016-2027)
6.3 North America Medications for Smoking Cessation Market Size by Application
6.3.1 North America Medications for Smoking Cessation Market Size by Application (2016-2021)
6.3.2 North America Medications for Smoking Cessation Market Size by Application (2022-2027)
6.3.3 North America Medications for Smoking Cessation Market Size by Application (2016-2027)
6.4 North America Medications for Smoking Cessation Market Size by Country
6.4.1 North America Medications for Smoking Cessation Market Size by Country (2016-2021)
6.4.2 North America Medications for Smoking Cessation Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Medications for Smoking Cessation Market Size (2016-2027)
7.2 Europe Medications for Smoking Cessation Market Size by Type
7.2.1 Europe Medications for Smoking Cessation Market Size by Type (2016-2021)
7.2.2 Europe Medications for Smoking Cessation Market Size by Type (2022-2027)
7.2.3 Europe Medications for Smoking Cessation Market Size by Type (2016-2027)
7.3 Europe Medications for Smoking Cessation Market Size by Application
7.3.1 Europe Medications for Smoking Cessation Market Size by Application (2016-2021)
7.3.2 Europe Medications for Smoking Cessation Market Size by Application (2022-2027)
7.3.3 Europe Medications for Smoking Cessation Market Size by Application (2016-2027)
7.4 Europe Medications for Smoking Cessation Market Size by Country
7.4.1 Europe Medications for Smoking Cessation Market Size by Country (2016-2021)
7.4.2 Europe Medications for Smoking Cessation Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Medications for Smoking Cessation Market Size (2016-2027)
8.2 Asia-Pacific Medications for Smoking Cessation Market Size by Type
8.2.1 Asia-Pacific Medications for Smoking Cessation Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Medications for Smoking Cessation Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Medications for Smoking Cessation Market Size by Type (2016-2027)
8.3 Asia-Pacific Medications for Smoking Cessation Market Size by Application
8.3.1 Asia-Pacific Medications for Smoking Cessation Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Medications for Smoking Cessation Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Medications for Smoking Cessation Market Size by Application (2016-2027)
8.4 Asia-Pacific Medications for Smoking Cessation Market Size by Region
8.4.1 Asia-Pacific Medications for Smoking Cessation Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Medications for Smoking Cessation Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Medications for Smoking Cessation Market Size (2016-2027)
9.2 Latin America Medications for Smoking Cessation Market Size by Type
9.2.1 Latin America Medications for Smoking Cessation Market Size by Type (2016-2021)
9.2.2 Latin America Medications for Smoking Cessation Market Size by Type (2022-2027)
9.2.3 Latin America Medications for Smoking Cessation Market Size by Type (2016-2027)
9.3 Latin America Medications for Smoking Cessation Market Size by Application
9.3.1 Latin America Medications for Smoking Cessation Market Size by Application (2016-2021)
9.3.2 Latin America Medications for Smoking Cessation Market Size by Application (2022-2027)
9.3.3 Latin America Medications for Smoking Cessation Market Size by Application (2016-2027)
9.4 Latin America Medications for Smoking Cessation Market Size by Country
9.4.1 Latin America Medications for Smoking Cessation Market Size by Country (2016-2021)
9.4.2 Latin America Medications for Smoking Cessation Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medications for Smoking Cessation Market Size (2016-2027)
10.2 Middle East & Africa Medications for Smoking Cessation Market Size by Type
10.2.1 Middle East & Africa Medications for Smoking Cessation Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Medications for Smoking Cessation Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Medications for Smoking Cessation Market Size by Type (2016-2027)
10.3 Middle East & Africa Medications for Smoking Cessation Market Size by Application
10.3.1 Middle East & Africa Medications for Smoking Cessation Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Medications for Smoking Cessation Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Medications for Smoking Cessation Market Size by Application (2016-2027)
10.4 Middle East & Africa Medications for Smoking Cessation Market Size by Country
10.4.1 Middle East & Africa Medications for Smoking Cessation Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Medications for Smoking Cessation Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Nicotek
11.1.1 Nicotek Company Details
11.1.2 Nicotek Business Overview
11.1.3 Nicotek Medications for Smoking Cessation Introduction
11.1.4 Nicotek Revenue in Medications for Smoking Cessation Business (2016-2021)
11.1.5 Nicotek Recent Development
11.2 Cipla
11.2.1 Cipla Company Details
11.2.2 Cipla Business Overview
11.2.3 Cipla Medications for Smoking Cessation Introduction
11.2.4 Cipla Revenue in Medications for Smoking Cessation Business (2016-2021)
11.2.5 Cipla Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Medications for Smoking Cessation Introduction
11.3.4 GlaxoSmithKline Revenue in Medications for Smoking Cessation Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Dr Reddy’s Laboratories
11.4.1 Dr Reddy’s Laboratories Company Details
11.4.2 Dr Reddy’s Laboratories Business Overview
11.4.3 Dr Reddy’s Laboratories Medications for Smoking Cessation Introduction
11.4.4 Dr Reddy’s Laboratories Revenue in Medications for Smoking Cessation Business (2016-2021)
11.4.5 Dr Reddy’s Laboratories Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Medications for Smoking Cessation Introduction
11.5.4 Johnson & Johnson Revenue in Medications for Smoking Cessation Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Fontem Ventures
11.6.1 Fontem Ventures Company Details
11.6.2 Fontem Ventures Business Overview
11.6.3 Fontem Ventures Medications for Smoking Cessation Introduction
11.6.4 Fontem Ventures Revenue in Medications for Smoking Cessation Business (2016-2021)
11.6.5 Fontem Ventures Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Medications for Smoking Cessation Introduction
11.7.4 Pfizer Revenue in Medications for Smoking Cessation Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 NovartisNjoy Inc
11.8.1 NovartisNjoy Inc Company Details
11.8.2 NovartisNjoy Inc Business Overview
11.8.3 NovartisNjoy Inc Medications for Smoking Cessation Introduction
11.8.4 NovartisNjoy Inc Revenue in Medications for Smoking Cessation Business (2016-2021)
11.8.5 NovartisNjoy Inc Recent Development
11.9 Perrigo and Reynolds American Inc.
11.9.1 Perrigo and Reynolds American Inc. Company Details
11.9.2 Perrigo and Reynolds American Inc. Business Overview
11.9.3 Perrigo and Reynolds American Inc. Medications for Smoking Cessation Introduction
11.9.4 Perrigo and Reynolds American Inc. Revenue in Medications for Smoking Cessation Business (2016-2021)
11.9.5 Perrigo and Reynolds American Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Medications for Smoking Cessation Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Non Nicotine Drugs
Table 3. Key Players of Nicotine Replacement Therapy (NRT)
Table 4. Global Medications for Smoking Cessation Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Medications for Smoking Cessation Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Medications for Smoking Cessation Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Medications for Smoking Cessation Market Share by Regions (2016-2021)
Table 8. Global Medications for Smoking Cessation Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Medications for Smoking Cessation Market Share by Regions (2022-2027)
Table 10. Medications for Smoking Cessation Market Trends
Table 11. Medications for Smoking Cessation Market Drivers
Table 12. Medications for Smoking Cessation Market Challenges
Table 13. Medications for Smoking Cessation Market Restraints
Table 14. Global Medications for Smoking Cessation Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Medications for Smoking Cessation Market Share by Players (2016-2021)
Table 16. Global Top Medications for Smoking Cessation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medications for Smoking Cessation as of 2020)
Table 17. Ranking of Global Top Medications for Smoking Cessation Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Medications for Smoking Cessation Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Medications for Smoking Cessation Product Solution and Service
Table 21. Date of Enter into Medications for Smoking Cessation Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Medications for Smoking Cessation Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Medications for Smoking Cessation Revenue Market Share by Type (2016-2021)
Table 25. Global Medications for Smoking Cessation Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Medications for Smoking Cessation Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Medications for Smoking Cessation Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Medications for Smoking Cessation Revenue Market Share by Application (2016-2021)
Table 29. Global Medications for Smoking Cessation Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Medications for Smoking Cessation Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Medications for Smoking Cessation Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Medications for Smoking Cessation Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Medications for Smoking Cessation Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Medications for Smoking Cessation Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Medications for Smoking Cessation Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Medications for Smoking Cessation Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Medications for Smoking Cessation Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Medications for Smoking Cessation Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Medications for Smoking Cessation Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Medications for Smoking Cessation Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Medications for Smoking Cessation Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Medications for Smoking Cessation Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Medications for Smoking Cessation Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Medications for Smoking Cessation Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Medications for Smoking Cessation Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Medications for Smoking Cessation Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Medications for Smoking Cessation Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Medications for Smoking Cessation Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Medications for Smoking Cessation Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Medications for Smoking Cessation Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Medications for Smoking Cessation Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Medications for Smoking Cessation Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Medications for Smoking Cessation Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Medications for Smoking Cessation Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Medications for Smoking Cessation Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Medications for Smoking Cessation Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Medications for Smoking Cessation Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Medications for Smoking Cessation Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Medications for Smoking Cessation Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Medications for Smoking Cessation Market Size by Country (2022-2027) & (US$ Million)
Table 61. Nicotek Company Details
Table 62. Nicotek Business Overview
Table 63. Nicotek Medications for Smoking Cessation Product
Table 64. Nicotek Revenue in Medications for Smoking Cessation Business (2016-2021) & (US$ Million)
Table 65. Nicotek Recent Development
Table 66. Cipla Company Details
Table 67. Cipla Business Overview
Table 68. Cipla Medications for Smoking Cessation Product
Table 69. Cipla Revenue in Medications for Smoking Cessation Business (2016-2021) & (US$ Million)
Table 70. Cipla Recent Development
Table 71. GlaxoSmithKline Company Details
Table 72. GlaxoSmithKline Business Overview
Table 73. GlaxoSmithKline Medications for Smoking Cessation Product
Table 74. GlaxoSmithKline Revenue in Medications for Smoking Cessation Business (2016-2021) & (US$ Million)
Table 75. GlaxoSmithKline Recent Development
Table 76. Dr Reddy's Laboratories Company Details
Table 77. Dr Reddy's Laboratories Business Overview
Table 78. Dr Reddy's Laboratories Medications for Smoking Cessation Product
Table 79. Dr Reddy's Laboratories Revenue in Medications for Smoking Cessation Business (2016-2021) & (US$ Million)
Table 80. Dr Reddy's Laboratories Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Medications for Smoking Cessation Product
Table 84. Johnson & Johnson Revenue in Medications for Smoking Cessation Business (2016-2021) & (US$ Million)
Table 85. Johnson & Johnson Recent Development
Table 86. Fontem Ventures Company Details
Table 87. Fontem Ventures Business Overview
Table 88. Fontem Ventures Medications for Smoking Cessation Product
Table 89. Fontem Ventures Revenue in Medications for Smoking Cessation Business (2016-2021) & (US$ Million)
Table 90. Fontem Ventures Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Medications for Smoking Cessation Product
Table 94. Pfizer Revenue in Medications for Smoking Cessation Business (2016-2021) & (US$ Million)
Table 95. Pfizer Recent Development
Table 96. NovartisNjoy Inc Company Details
Table 97. NovartisNjoy Inc Business Overview
Table 98. NovartisNjoy Inc Revenue in Medications for Smoking Cessation Business (2016-2021) & (US$ Million)
Table 99. NovartisNjoy Inc Recent Development
Table 100. Perrigo and Reynolds American Inc. Company Details
Table 101. Perrigo and Reynolds American Inc. Business Overview
Table 102. Perrigo and Reynolds American Inc. Medications for Smoking Cessation Product
Table 103. Perrigo and Reynolds American Inc. Revenue in Medications for Smoking Cessation Business (2016-2021) & (US$ Million)
Table 104. Perrigo and Reynolds American Inc. Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Medications for Smoking Cessation Market Share by Type: 2020 VS 2027
Figure 2. Non Nicotine Drugs Features
Figure 3. Nicotine Replacement Therapy (NRT) Features
Figure 4. Global Medications for Smoking Cessation Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retailer Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Medications for Smoking Cessation Report Years Considered
Figure 9. Global Medications for Smoking Cessation Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Medications for Smoking Cessation Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Medications for Smoking Cessation Market Share by Regions: 2020 VS 2027
Figure 12. Global Medications for Smoking Cessation Market Share by Regions (2022-2027)
Figure 13. Global Medications for Smoking Cessation Market Share by Players in 2020
Figure 14. Global Top Medications for Smoking Cessation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medications for Smoking Cessation as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Medications for Smoking Cessation Revenue in 2020
Figure 16. Global Medications for Smoking Cessation Revenue Market Share by Type (2016-2021)
Figure 17. Global Medications for Smoking Cessation Revenue Market Share by Type (2022-2027)
Figure 18. North America Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Medications for Smoking Cessation Market Share by Type (2016-2027)
Figure 20. North America Medications for Smoking Cessation Market Share by Application (2016-2027)
Figure 21. North America Medications for Smoking Cessation Market Share by Country (2016-2027)
Figure 22. United States Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Medications for Smoking Cessation Market Share by Type (2016-2027)
Figure 26. Europe Medications for Smoking Cessation Market Share by Application (2016-2027)
Figure 27. Europe Medications for Smoking Cessation Market Share by Country (2016-2027)
Figure 28. Germany Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Medications for Smoking Cessation Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Medications for Smoking Cessation Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Medications for Smoking Cessation Market Share by Region (2016-2027)
Figure 38. China Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Medications for Smoking Cessation Market Share by Type (2016-2027)
Figure 46. Latin America Medications for Smoking Cessation Market Share by Application (2016-2027)
Figure 47. Latin America Medications for Smoking Cessation Market Share by Country (2016-2027)
Figure 48. Mexico Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Medications for Smoking Cessation Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Medications for Smoking Cessation Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Medications for Smoking Cessation Market Share by Country (2016-2027)
Figure 54. Turkey Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Medications for Smoking Cessation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Nicotek Revenue Growth Rate in Medications for Smoking Cessation Business (2016-2021)
Figure 58. Cipla Revenue Growth Rate in Medications for Smoking Cessation Business (2016-2021)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Medications for Smoking Cessation Business (2016-2021)
Figure 60. Dr Reddy's Laboratories Revenue Growth Rate in Medications for Smoking Cessation Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Medications for Smoking Cessation Business (2016-2021)
Figure 62. Fontem Ventures Revenue Growth Rate in Medications for Smoking Cessation Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Medications for Smoking Cessation Business (2016-2021)
Figure 64. NovartisNjoy Inc Revenue Growth Rate in Medications for Smoking Cessation Business (2016-2021)
Figure 65. Perrigo and Reynolds American Inc. Revenue Growth Rate in Medications for Smoking Cessation Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
禁煙およびニコチン脱依存症製品のグローバル市場調査 2019年 The global Smoking Cessation and Nicotine De-Addiction Products market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Smoking Cessation and Nicotine De-Addiction Products volume and value at global level,…- 禁煙およびニコチン脱依存症製品のグローバル市場調査 2019年 The global Smoking Cessation and Nicotine De-Addiction Products market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Smoking Cessation and Nicotine De-Addiction Products volume and value at global level,…
- 世界のNRT禁煙補助用品市場規模・現状・予測（2021年-2027年） Smoking cessation Aids, a product that Aids individuals in quitting smoking, essentially replaces smoking, though, without the harmful effects of smoking. Market Analysis and Insights: Global NRT Smoking Cessation Aids Market The global NRT Smoking Cessation Aids market size is projected to reach US…
- 世界の調剤薬局市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Compounding Pharmacies Market The global Compounding Pharmacies market size is projected to reach US$ 13500 million by 2027, from US$ 11180 million in 2020, at a CAGR of 2.7% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, t…
- 世界の禁煙用製品市場規模・現状・予測（2021年-2027年） The smoking cessation and nicotine de-addiction market is categorized into three major segments including drug therapy, Nicotine Replacement Therapy (NRT), and Electronic cigarettes (E-cigarettes). Market Analysis and Insights: Global Anti-Smoking Products Market The global Anti-Smoking Products mar…